<scp>FMOD</scp> expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot studyMarc Sorigué, Lurdes Zamora, Esther Plensa et al.|Cytometry Part B Clinical Cytometry|2020Cited by 15
Flow cytometry to detect bone marrow involvement by follicular lymphomaMercè Aren, Marc Sorigué, Sílvia Marcé et al.|Cytometry Part B Clinical Cytometry|2022Cited by 5
Leucemia aguda mieloblástica con reordenamiento de MOZ/CBPEsther Plensa, Fuensanta Millá, Josep‐María Ribera et al.|Medicina Clínica|2004Cited by 0
Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase InhibitorsSílvia Marcé, Fuensanta Millá, Lurdes Zamora et al.|Blood|2011Cited by 0
Clinical and Biological Characteristics According to the Burden of JAK2V617F Mutated Allele in BCR-ABL Negative MPNsLurdes Zamora, Fuensanta Millá, Marta Cabezón et al.|Blood|2012Cited by 0